VITAL study

Study / Research

A primary prevention study involving 20,000-25,000 relatively healthy Americans, which used 850 mg/day of EPA+DHA (one Lovaza capsule) and showed a 20% reduction in heart attacks and fatal heart attacks, particularly in those with low fish intake, despite media reports of a 'neutral' outcome.

Mentioned in 1 video

Videos Mentioning VITAL study

#83 – Bill Harris, Ph.D.: Omega-3 fatty acids

#83 – Bill Harris, Ph.D.: Omega-3 fatty acids

Peter Attia MD

A primary prevention study involving 20,000-25,000 relatively healthy Americans, which used 850 mg/day of EPA+DHA (one Lovaza capsule) and showed a 20% reduction in heart attacks and fatal heart attacks, particularly in those with low fish intake, despite media reports of a 'neutral' outcome.